Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JAK3-IN-14 is a potent, selective and orally active FLT3 inhibitor, with IC50s of ∼40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 226.00 | |
5 mg | In stock | $ 653.00 | |
10 mg | In stock | $ 952.00 | |
25 mg | In stock | $ 1,390.00 | |
50 mg | In stock | $ 1,880.00 | |
100 mg | In stock | $ 2,560.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 568.00 |
Description | JAK3-IN-14 is a potent, selective and orally active FLT3 inhibitor, with IC50s of ∼40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively. |
Molecular Weight | 287.32 |
Formula | C18H13N3O |
CAS No. | 454234-24-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (174.02 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JAK3-IN-14 454234-24-3 Angiogenesis Tyrosine Kinase/Adaptors FLT (3Z)5(pyridin3yl)3[(1Hpyrrol2yl)methylidene]2,3dihydro1Hindol2one inhibitor inhibit